Skip to content

Reducing relapse and recurrence in depression with continuation Cognitive Therapy.

Reducing relapse and recurrence in depression with continuation Cognitive Therapy: A randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25030
Enrollment
214
Registered
2010-11-11
Start date
2011-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrence or Relapse of Major Depression Disorder

Interventions

Short-term continuation PCT (C-PCT) consist of 8 sessions that is offered as sequential treatment after response to A-CT. The effectiveness of C-PCT has been evaluated in earlier trials (Bockting et a
2009). CT is directed at the identification of maladaptive cognitions and the development of a personal prevention strategy. C-PCT (Bockting et al., 2009) is an adapted type of cognitive therapy spe

Sponsors

Arkin, mental health care institute Amsterdam, Department of Psychology of the University of Groningen, Vanderbilt University, Nashville, Vrije Universiteit Amsterdam, Faculteit der Geneeskunde Huisarts- en Verpleeghuisgeneeskunde, Trimbos Instituut, Innovation Centre of Mental Health & Technology, Vrije Universiteit Amsterdam, Faculteit der Aard- en Levenswetenschappen Gezondheidswetenschappen: Health Economics and Technology Assessment
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Two or more previous depressive episodes indicating high risk for relapse/recurrence; 2. In remission according to DSM-IV criteria; 3. A current score of <14 on the Hamilton Rating Scale for Depression; 4. During the acute phase of the last episode, patients received CT at the Arkin Mental Health Care Institute.

Exclusion criteria

Exclusion criteria: 1. Current mania or hypomania or a history of bipolar illness; 2. Any psychotic disorder (current and previous); 3. Alcohol or drug misuse; 4. Predominant anxiety disorder; 5. Insufficient mastering of the Dutch language.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the cumulative proportion of relapses/recurrences in a survival-analysis over a follow-up period of 15 months after the start of the preventive therapy as measured with the ‘Structural Interview for DSM-IV (SCID) using the Longitudinal Interval Follow-up Evaluation (LIFE), which provides a retrospective assessment of depression recurrences since the time of the last evaluation.

Secondary

MeasureTime frame
1. The severity of depressive symptoms as measured with the 'Inventory of Depression Symptomatology' (IDS-SR); 2. Number of relapses (SCID); 3. Anxiety (SCID); 4. Suicidal thoughts (SCID); 5. Social and interpersonal functioning (IIP); 6. Well-being, quality of life (EQ-5D); 6. Consumption of mental health care and degree of work absence (TIC P).

Contacts

Public ContactJ. Dekker

Department of Rehabilitation Medicine, VUmc PO Box 7057

j.dekker@vumc.nl+31 020 4440763

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)